Antiviral drugs were rapidly implemented into clinical practice for the treatment of high-risk patients with COVID-19, prompting the development of statewide guidelines. This South-Australian study reviewed guideline adherence, assessed prescribing patterns and highlighted the inappropriate management of relative drug-drug interactions and dosing for renal function. Additionally, it evaluated the impact of inappropriate antiviral drug use and suggested methods to improve quality use of medicines.
Keywords: COVID-19; living guidelines; molnupiravir; nirmatrelvir/ritonavir; prescribing; remdesivir.
© 2023 Royal Australasian College of Physicians.